Replies to post #39499 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

You can also take out the naked shorting aspect and apply virtually every other manipulation tactic mentioned in the article and recognize it in ADXS to a "t". It's like you are reading a history of ADXS stock when you read the article.

[gbrown6332]

This lengthy piece has a similar theme to the naked short write up XenaLives posted yesterday. It outlines the prolonged short attack on Northwest Bio which traded near $12 in July 2015. I have not researched NWBO science but they do have one phase III and a couple of phase I/II trials in flight. Short interests peaked at 39% during 2016. They're trading today between .16 and .17 cents.

https://smithonstocks.com/northwest-analysis-of-a-coordinated-short-selling-attack-against-the-stock-nwbo-4-69/

The writer was/is a pissed off Investor so his feelings about Hedge Fund destruction of NWBO and the total lack of regulatory response are clearly stated throughout the write up. The point is made, many big investors and financial institutions will not go near a company that has been isolated for a Hedge fund short attack.

Hard to see how this kind of blatant theft can be ignored or tolerated indefinitely by authorities before retail investors simply decide it’s not worth the trouble or the risk to invest in small biotech startups. That seems ass backwards to the notion medical innovation should be encouraged and publicly funded.

Stating the obvious. It will take a positive development on the EU front, getting something like AT-014 approved or an outright sale of the company to break the death grip of Hedge Fund parasites who appear to have little reason or threatening catalyst to relent at this point in time.

G.B.